[2] [1] The National Institute for Health and Care Excellence (NICE) guidance for type 2 diabetes management (NG28) recommends SGLT2 inhibitors as the preferred option for patients with established cardiovascular disease, while GLP-1 receptor agonists like semaglutide are positioned based on glycaemic control and weight management criteria
Technical note Marie Byenfeldt, Patrik Nasr, Anna Lindam, Christer Grnlund, Mattias Ekstedt, Peter Lundberg, Johan Kihlberg European Journal of Radiology .2026
Transparent Labs Creatine HMB is an evidence-based step forward for creatine supplementation, which is well-known to enhance muscle growth and athletic performance (e.g muscle endurance and strength)
BrierleyDIHoltMKSinghAde AraujoAMcDougleMVergaraMet al
It is being studied to assess its safety, effectiveness and long-term impact on weight and metabolic health